Malignant gliomas are a leading cause of death among young children and adults, according to data recorded in the Central Brain Tumor Registry of the United States. These tumors appear to be heterogeneous, and they develop by different mechanisms involving various genetic pathways, all of which ultimately lead to a malignant phenotype. Despite advances in neurosurgical techniques and neurooncology treatment regimens, the overall prognosis in patients with these tumors remains dismal. Moreover, in current studies characteristic genetic alterations have been identified in gliomas, which indicates that better understanding of the molecular biology of malignant gliomas could have an impact on disease treatment.
normalities in the pathways that are regulated by growth factor receptors (including EGFR upregulation), and apoptotic regulators, of which PTEN may have an important role. Chromosomal abnormalities associated with the known genetic changes have been described on chromosomes 7, 9, 10, 12, 13, 17, and 19. 27 Consequently, duplicating all of these changes in a single animal model has proven quite difficult and remains one of the biggest impediments to our understanding of this disease.
In many glioma studies, investigators have relied on cell lines developed in rats in which the tumors have been chemically induced. These tumors exhibit diverse morphological phenotypes that include astrocytomas, glioblastomas, and gliosarcomas. Some of the cell lines used in rats as brain tumor models include C6, 9L, F98, and RG2. The four rat glioma cell lines used in our experiments were originally derived from the mutagenicity that developed after treatment with a nitrosourea derivative. The C6 rat glioma line was produced following treatment of a Wistar rat with N-methylnitrosourea. 39 Likewise, the 9L gliosarcoma cell line was produced following treatment of Fischer rats with N-methylnitrosourea. Both the F98 and RG2 glioma cell lines were generated from Fischer rats after treatment with N-ethyl-N-nitrosourea. 26 Classification of these cell lines in relation to gliomas has been done solely on the basis of histopathological features and behavior, as opposed to gene expression profiles. The F98 and RG2 cell lines have been reported to exhibit growth and invasive characteristics similar to those of human glioblastomas. 5 In addition, because of their weakly immunological characteristics, both the F98 and RG2 lines have been proposed as suitable models for human glioma studies. In contrast, the C6 and 9L cell lines seem to have fallen out of favor as glioma models for different reasons. Although C6 is an astrocytoma, its immunological tendencies are a major setback, and the 9L cell line has been classified as a gliosarcoma.
A noteworthy limitation of the classification of rat cell lines based on morphological and growth characteristics is that such a classification overlooks subtle differences in genotype profiles. The lack of crucial genotype information about the rat glioma models complicates the task of predicting how human gliomas would respond to therapies that are based on these animal models. It would therefore seem intuitive that the clinical utility of data from studies in which glioma cell lines are used in animal models is highly dependent on similarities in genotype response to proposed therapy when transferred to human trials.
Because all four rat cell lines have been compared to human gliomas with regard to morphology and growth properties, we were interested in determining if there is conformity in expression with respect to specific genes that have been implicated in human glioma tumorigenesis. More importantly, we were interested in determining which of the four cell lines has a gene expression profile closest to human gliomas, notably GBM. Despite the extensive use of these four cell lines, there has been no previous systematic comparison of differential gene expression through microarray analysis. Hence, the aim in this study was to use current microarray technology to examine large-scale gene expression in each of the rat cell lines to ascertain similarities and determine which cell line most closely mimics human gliomas genetically.
MATERIALS AND METHODS

Cell Culture
Stem cells from the central nervous system were obtained in 16-day gestational Sprague-Dawley rat pups. The handling and procedures protocols were approved by the University of Iowa Animal Care and Use Committee. The tissue was incubated in 0.01% DNase, minced into 0.3-mm fragments, titrated, and maintained in serumfree media in 5% CO 2 . The central nervous system stem cells were introduced to ciliary neurotrophic factor, which resulted in the differentiation of cells into mature astrocytes as determined using glial fibrillary acidic protein immunostaining. The differentiated cells were maintained in Dulbecco modified Eagle medium containing 10% fetal bovine serum and penicillin/streptomycin. The rat glioma tumor cell lines (9L, C6, F98, and RG2) were cultured in Dulbecco modified Eagle medium with the same additives.
Total RNA Extraction
Purified total RNA was isolated using a multistep approach. A commercially available kit (RNeasy; Qiagen, Westburg, The Netherlands) was used according to the manufacturer's protocol, followed by TRIzol reagent (Life Technologies, Grand Island, NY). The total RNA eluted was subjected to DNase treatment, phenol and chloroform extraction, and repeated precipitation. The purified RNA sample was resuspended in RNase-free water. The concentration and yield of the total RNA was then determined.
Expression Arrays for cDNA
In triplicate, rat cDNA expression array membranes (Clontech, Palo Alto, CA) containing 1176 known genes were used to identify genes with variations in their expression profile. A radiolabeled cDNA probe was synthesized using total RNA as the template and the reagents and specific primers provided in the expression array kit. The [␣- 32 P]deoxyadenosine 5Ј-triphosphate was purchased from Amersham Biosciences, Piscataway, NJ. The unincorporated [␣- 32 P]deoxyadenosine 5Ј-triphosphate was removed using spin-column chromatography. The purified radiolabeled cDNA probes were quantitated and hybridized to the Atlas Rat 1.2 Array expression membrane (Clontech) overnight. Following high-stringency washes, the membranes were exposed to x-ray film. The resulting autoradiographs were scanned and expression levels were determined using commercially available software (AtlasImage 2.0; Clontech).
Data Analysis
Microarray data analysis was done to identify differentially expressed genes between malignant rat cell lines and normal rat astrocyte cells. To examine these differentially expressed genes, four different rat cell lines (C6, 9L, F98, and RG2) were used in an attempt to characterize the similarities and differences. This comparison can also be extended to analyze the differences between disease and normal states of these cell lines. Each cell line had three replicates and their microarray probe intensities were analyzed using R, a language for statistical analysis and graphics. 18 The various cell line intensities were analyzed identically to avoid bias. Individual microarray background intensities were subtracted from the appropriate microarray intensities. Probes were filtered out if they did not show intensities above their background level for both the malignant cell line microarray and their corresponding rat normal astrocyte microarray. The data were filtered to remove the genes in which the radioactive counts could not be determined unequivocally because of "bleedover" from the radioactive hybridization of genes immediately adjacent. The data were then analyzed using two different methods. The initial analysis was performed using the commercially available GeneSpring software (Silicon Genetics, Redwood, CA).
In the second independent analysis for each cell line, the remaining filtered probes were intersected for all replicates and used for statistical analysis. All intensities were log2 transformed, and the ratio of malignant cell line to normal rat astrocyte was computed. The ratios were normalized using robust loess normalization of each microarray individually before computing t statistics.
The experiments were designed so that the mRNA sample (that is, astrocytes and each tumor cell line) was used in arrays in triplicate. Initially, the automated high-resolution GeneSpring software program was used to normalize and analyze relative gene expression profiles of individual tumor cell lines with respect to the rat astrocyte control cells. After normalization, the genes exhibiting at least a threefold upor downregulation were considered significant. Although a threefold change in gene expression is in itself robust, such a change had to be consistent for two of the three replicas to be considered. To validate the results obtained by examining the fold change with the GeneSpring software, we analyzed the data by using t statistics to remove any bias that may have presented itself due to experimental variation. This analysis was done independently of the GeneSpring software. The raw data were filtered to remove probes whose expression intensities for control and sample fell below a background threshold. Each microarray was normalized individually by using loess (nonlinear smoothing) normalization followed by median-chipintensity scaling. This is demonstrated by the log2 ratio quartiles before and after loess normalization, which show similar ranges between replicates and across all four malignant cell lines (Fig. 1) . To compensate for the low replicate number, a modified t statistic was used to provide a more reliable estimate of gene-specific variability. Initially, genes were considered significant if they satisfied a minimal probability value cutoff of 0.05. By increasing the stringency and the confidence of this analysis, only those genes that met a probability value cutoff of 0.01 underwent further analysis.
For each gene, a t statistic, 11 a penalized t statistic, and a medianchip scaled t statistic were computed to rank the genes. This added an increasing level of robustness compared with the fold change (ratio) alone in an attempt to account for experimental variation. The t statistic takes into account differing gene-specific variation across arrays. Additionally, because of the small sample size, the penalized t statistic was used. The denominator is inflated by a penalty parameter to provide a more reliable variance estimate. Finally, a median-intensity chip was computed for each cell line and used to scale each one before the final t statistic was calculated.
The RT-PCR Assay
The PCR primer sequences were designed to confirm the expression levels of genes that demonstrated differential expression through microarray analysis (Table 1) .
The RT-PCR assays were performed using the Qiagen OneStep RT-PCR kit according to the manufacturer's recommended protocol. The total volume was 50 l. In addition to the primers, the reaction mix included RNase-free water, 5ϫ RT-PCR buffer, 10 mM deoxynucleoside triphosphates, and the enzyme mix provided in the kit.
RESULTS
Atlas 1.2 rat cDNA microarrays (Clontech) containing 1176 genes identified differential expression profiles of each tumor cell line (C6, 9L, F98, and RG2) when we compared them with rat astrocytes. The microarrays contained genes whose protein products have been previously characterized as cell surface antigens, transcription factors, cell cycle regulators, immune system modulators, transport, receptor proteins, oncogenes, and tumor suppressors. Of particular interest is the fact that included on the microarrays there are gene products (such as the Rb and p53 products) that have been implicated in human gliomas.
Differential Gene Expression of Tumor Cell Lines Relative to Rat Astrocytes
We compared the genes' expression levels independently in the four rat tumor cell lines (C6, 9L, F98, and RG2) relative to astrocytes derived from rat stem cells (control group). Significant differential gene expression patterns demonstrating an increase or decrease were observed in all rat glioma cell lines.
When the GeneSpring software was used, there were a substantial number of genes in the C6 cell line whose expression differed from the astrocyte control group: 233 genes had an increase in their expression, whereas 218 showed decreased expression. The 9L cell line had the lowest number of genes whose expression was altered compared with mature rat astrocytes, with an upregulation of 196 and a downregulation of 234 gene products. A similar analysis of the F98 cell line revealed 447 differentially expressed genes; 217 genes exhibited an increase in expression, whereas the remaining 230 had a relative decrease in expression. The RG cell line had the largest number of differentially expressed genes; of the 471 differentially expressed products, 229 displayed an increase in expression, whereas 242 showed a decrease in expression compared with astrocytes. In essence, the C6 had the most upregulated profile and the RG2 had the most downregulated profile.
The number of genes in which differential expression was demonstrated using our independent analysis with a probability value cutoff of 0.01 differed substantially from the absolute values generated by the GeneSpring analysis. For example, the total number of genes demonstrating a change in expression for the C6 line was 152, compared with 451 in the fold change analysis. Nevertheless, the ratio of genes with increased compared with decreased expression indicated very similar trends for each of the cell lines in both analyses (Table 2) . Likewise, the C6 cell line again had the most genes that displayed an overall change in expression. The genes identified in each of the analyses were intersected, and genes whose functions have been implicated in glioma tumorigenesis were subjected to further scrutiny.
The Rat Glioma Cell Lines
The C6 Line. Histologically, the C6 cell line has been classified as an astrocytoma, and this cell line demonstrated the greatest number of genes whose expression was similar to that reported for human brain tumors. On examination of genes encoding growth factors and those involved in the signaling pathways, many showed an increase in expression, including PDGF␤ and IGF-I as well as the EGFR, and ErbB3/HER3 precursor proteins. An increase in the expression of the TGF␣ precursor was observed; however, we did not observe an increase in the TGF␣ gene itself. Although there was an increase in expression of the Rb gene, we saw no change in p53 gene expression, contrary to what we would have predicted based on the current literature. 20, 32, 43, 45 Another modulator of growth activity in cells is the IGF. Modulation of growth is believed to occur via autocrine stimulation of the IGF receptor. Increased expression of the IGF subtypes IGF-I and -II has been reported in human gliomas.
14 The subtype IGF-I was overexpressed only in the C6 cell lines. Surprisingly, IGF-II expression was decreased in all tumor cell lines compared with expression in normal astrocytes.
Although we observed an increase in expression of many of the growth factor genes in the C6 cell line, we also observed a decrease in expression of two members of the FGF family (namely FGF-9 and FGF-10) and the IGF-II gene, compared with findings in the astrocyte control group. In contrast to the increase in the expression of the PDGF␤ gene seen in the C6 cell line, there was a decrease in expression of the gene that encodes its receptor (PDGFR␤) in this line as well as the other cell lines tested.
The intracellular signaling pathways also included members of the Ras protein family. Compared with that in a normal brain, Ras activity is markedly increased in human gliomas. 15 In our studies, we observed a similar increase in Ras expression in the C6 cell lines. Furthermore, the Ras guanosine triphosphatase activator protein also displayed an increase in expression, indicating that even though Ras expression was upregulated, the simultaneous increase in the Ras guanosine triphosphatase activator protein kept the Ras pathway under control. Nevertheless, this observation was not true for any of the other cell lines examined.
The 9L Line. The 9L cell line has a sarcomatous appearance histologically and has been used in many brain tumor studies in the rat model. Nevertheless, many of the increases in gene expression of growth factors that were noted in the C6 cell line were not observed in the analysis of 9L cells when they were compared with normal rat astrocytes. In fact, the TGF␣ precursor was the only enzyme for which an increase in gene expression was observed in both analyses. Interestingly, although EGFR interacts with multiple ligands including TGF␣, 9L was the only cell line that demonstrated a concomitant increase in the expression of both genes.
As in the C6 line, there was a decrease in expression of the FGF-9 gene and a diminution of PDGFR␤ gene expression. In addition to these reductions in gene expression, there was also a loss of expression for the FGF-2 and the FGFR-1 genes.
The F98 Line. The F98 cell line has been classified histologically as an anaplastic glioma, and it has been reported that its characteristic growth properties closely resemble human GBM. 5 For this reason the cell line is thought to be particularly useful in brain tumor studies in the rat model. Fig. 1 . Boxplot images for the individual microarray replicates from before and after loess normalization. Each panel groups the boxplots by their corresponding rat malignant cell line (C6, 9L, F98, and RG2). Within each panel, the first three boxplots (labeled 1, 2, and 3) are prenormalized log2 transformed intensity ratios and display the need for normalization. The distribution of the ratios is not sufficiently similar to perform a statistical comparison. The remaining three boxplots per panel (labeled 1n, 2n, and 3n) are depicted after loess normalization. All four malignant cell lines show similar quartile ranges and present a similar 50th percentile. Additionally, the log2 scale range for all four panels showed relatively similar extreme values. This will allow for a more reliable estimate of gene-specific variability in an effort to remove experimental bias.
The molecular phenotype demonstrated when investigating the expression of growth factors showed an increase in the expression of PDGF␤, Rb, and Ras, similar to findings in the C6 line. Nevertheless, the F98 cell line was the only one to exhibit an increase in expression of the EGFR. In contrast to the C6 and 9L cell lines that we tested, an increase in expression of both cyclin D1 and cyclin D2 genes was noted. Because cyclin D1 is a cofactor with CDK 4 in the transition from G1 arrest to the S phase of DNA synthesis, one that acts by inactivating the RB tumor suppressor protein, we also examined the expression of CDK 4. We found that there was no significant change in expression of CDK 4 between the normal rat astrocytes and the F98 tumor cell line.
The RG2 Line. Like the F98 cell line, the RG2 tumor cells display an infiltrative growth pattern, are refractory to many therapeutic modalities, and are nonimmunogenic in syngeneic hosts, thus making the cells a relatively good model for human glioma. These cells have also been posited as the equivalent of human GBM. Examination of the gene expression profile demonstrated increased expression of growth factor components such as PDGF␤, IGF-I, and the Ras oncogene. There was a similarity to the C6 cell line in that both cell lines demonstrated an increase in expression of the ErbB3/HER3 precursor mRNA. Similar to the F98 cell line, RG2 cells exhibited an increase of expression of the cyclin D2 gene.
Differential Gene Expression Universal to all Tumor Cell Lines Relative to Rat Astrocytes
The first analyses were designed to examine the expression of a select number of genes whose function and role in brain cancer have been elucidated. Because of the large number of genes whose expression displayed either up-or downregulation compared with rat astrocytes, an examination of the changes in gene expression that were shared in all cell lines was conducted. This analysis narrowed the number of genes that were up-or downregulated consistently in all four cell lines compared with mature astrocytes, and it provides the focus of our discussion.
Real-Time Quantitative RT-PCR Assays of Selected Genes
Real-time quantitative RT-PCR analysis was performed using a subset of genes to validate our microarray findings. These were genes that were found to be differentially expressed when we compared the tumor cell lines to rat astrocytes. Total RNA from each of the four rat cell lines and rat astrocytes were analyzed for the expression of FABP, ID-2, IRF, FasL, IGF, integrin-␣, and Rb. Our RT-PCR results were concordant with our microarray data (data not shown).
DISCUSSION
The origins of cancer are complex, but appear to involve three major steps: initiation (accumulation of genetic alterations); promotion (uncontrolled growth); and progression (selective survival of transformed cells and the capacity of these cells to invade distant sites). As cells proceed through these major changes, several growth factors and signaling pathways have been implicated in the dysregulation of the cell cycle that results in cell proliferation, and the loss of apoptotic signals have equally been noted. Ultimately, these activities result in increased accumulation of genetic changes. Although cellular pathways are intertwined, the genes were divided into groups based on their broad function. Although the data presented do not examine the entire rat genome, our analysis probes genes whose functions have been implicated in glioma proliferation, infiltration, and neovascularization, and is presented in the context of key genetic processes.
Glioma Proliferation
Although there are a significant number of genes that demonstrated a change in expression in all four cell lines, the pathways involved are more limited. For example, growth factors and their corresponding receptors initiate signaling cascades that affect the downstream behavior of transformed cells, resulting in tumor progression and migration. One such molecule, PLC␥, is induced by members of several growth factor families, including VEGF, EGF, PDGF, IGF-I, and FGF. It is required for mobility of many types of cells, and certainly for the infiltration and metastasis of carcinoma cells, including human glioma. 25 The involvement of this enzyme in dysregulated cell migration was demonstrated by the inhibition of PLC␥ in a rat brain tumor model that resulted in the loss of cell mobility into normal brain tissue from GBM explants. We found an increase in expression of the PLC␥ gene in all four cell lines, indicating that this enzyme may be an important molecular switch in glioma progression and metastasis. Taken together, the fact that there was increased expression of several of the growth factors and an increase in PLC␥ gene expression, and that PLC␥ is common to each of the signaling pathways, this downstream signaling molecule may be an attractive target for future therapies.
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Genetic characterization of commonly used rat glioma cell lines 5 Dysregulation of cyclins, CDKs, and CDK inhibitors has been reported in many human cancers. Cell proliferation is controlled in most mammalian cells by the p16/cyclin D1/Rb cascade, and alteration of just one of these components is sufficient to activate the entire pathway. Increased expression of cyclins such as D1, D2, and D3 occurs in some human brain tumors. 6 It has been demonstrated that the proliferative state of brain tumors is reflected by cyclin overexpression, and that overexpression of cyclin D1 seems to be an early event in the transformation process. 9, 38 The increased expression of cyclin D1 stimulates the activity of MMPs, which results in cell motility and invasion of glioma cells, notably GBM. 4 In the two cell lines histologically described as being like GBM (F98 and RG2), cyclin D1 demonstrated increased expression, but an increase in cyclin D2 expression was only noted in the F98 cell line.
The PCNA gene has been associated with DNA synthesis during the S phase and cell proliferation. This gene interacts with proteins involved in the regulation of the cell cycle, such as the cyclin-CDK complexes. Evidence indicates that PCNA may facilitate the interaction between the individual cyclin-CDK complexes and their substrates. 30 Our data show an increase in expression of this antigen in all the cell lines reviewed, indicating that the stimulation of pathways through the growth factor receptors initiates an increase in cell proliferation.
The most favorable animal model will demonstrate near perfect agreement between all of the individual entities. Duplicating all of these changes in a single animal model is unlikely and may contribute to the difficulty in the translation of findings in animal models to use in clinical care. Although the up-and downregulation of many of the genes were as predicted based on the literature, unexpected variations were also encountered in the rat model. For example, inspection for expression of the beta chain of PDGF and its concomitant receptor demonstrated conflicting results. There was a significant increase in expression of PDGF␤ in only the C6 and F98 cell lines, but there was a decrease in PDGFR␤ gene expression compared with that found in normal rat astrocytes.
In addition to PDGF, cell growth is modulated by several other growth factors, including FGF, EGF, IGF, and their respective receptors. Increased expression of both FGF and FGFR has been noted in gliomas, indicating a role for these factors in tumor growth. 48 Three FGF subtypes were examined, namely FGF-5, FGF-9, and FGF-10. The general trend was a decrease in FGF expression in the tumor cell lines relative to rat astrocytes. Although this finding was unexpected, it should be noted that alternative mechanisms for increased FGF-mediated signal transductions have been described in gliomas (see following discussion).
The EGFR interacts with multiple ligands, including TGF␣ and EGF, to promote cell growth. In gliomas, coexpression of ligand and receptor indicates that an autocrine loop is necessary for tumor growth, and increased TGF␣ levels are typically associated with high-grade tumors. A TGF␣ precursor was overexpressed in C6 and 9L cell lines compared with normal astrocytes. Nevertheless, a concomitant increase in TGF␣ and the EGFR was noted only in the 9L tumor cell line. Increased expression of IGF subtypes IGF-I and -II have been reported for human gliomas.
14 On analysis, only the C6 cell line demonstrated an increase in IGF-I, and no change in expression was noted in any of the other cell lines. In all of the rat tumor cell lines a decrease in IGF-II expression was noted compared with its expression in normal rat astrocytes, a deviation from findings reported in the literature.
The p53 tumor suppressor protein is a key regulator of the cell cycle. Its activation produces downstream signals, which ultimately prevent cell-cycle progression and culminate in apoptosis. Mutation of this protein is known to occur early in glioma development and has been well documented. 20, 32, 45 When we compared our tumor cell lines with normal rat astrocytes, we observed no significant differential expression of p53.
Another cell cycle regulator/tumor suppressor of equal importance in glioma biology is the Rb gene. Phosphorylation of Rb promotes cell-cycle progression by dissociation of Rb from the transcription factor E2F. 40 Genetic alterations of Rb appear to occur sometime during in glioma transformation. 1, 10 The Rb gene was differentially expressed in the rat glioma cell lines. In relation to rat astrocytes, Rb was overexpressed in the C6 and F98 cell lines but underexpressed in the RG2 cell lines.
Microsatellite instability has been documented in gliomas. 3, 44 They consist of short tandem repeat sequences found throughout the genome, 22 and are prone to replication errors in light of their repeat structures. The DNA mismatch repair genes are very important in correcting such errors of replication. Mutations in DNA mismatch repair genes are well documented in human tumors such as colorectal cancer. 22, 34 A decreased or absent expression of DNA mismatch repair genes (hMLH1 and hMSH2) correlated with gliomas that exhibited a higher degree of instability. 44 There was no differential expression of hMLH1 in any of the rat glioma cell lines. We did observe a decrease in hMSH2 expression, however, in the 9L cell lines.
Interaction of FasL and its receptor Fas destines cells to apoptosis, with increased FasL expression being reported in gliomas. 37, 46, 47 There was a significant decrease in expression of the apoptosis-inducible protein FasL in all of the rat glioma cell lines relative to rat astrocytes. Nevertheless, there is evidence that upregulation of the Fas receptors leads to increased apoptosis and survival in rats with malignant gliomas. 12, 41 Cell surface antigens play a very important role in processes including signal transduction and cell adhesion, and have been implicated in several aspects of tumor biology. The CD9 molecule is a glycoprotein cell surface molecule, which is normally expressed in the myelin sheaths of nerves. 23 Increased expression of CD9 has been reported in high-grade astrocytic tumors, and as a result CD9 has been suggested as a marker for the degree of malignancy in gliomas. Because our tumor cell lines encompassed various grades of glioma, based on our histopathological findings, we were interested in verifying concordance of CD9 expression in human gliomas vis à vis our cell lines. There was a significant increase in CD9 expression in the C6 astrocytoma cell line but significantly decreased expression in the F98 cell line. Because both the F98 and RG2 were more advanced grades of gliomas compared with C6 according to histopathological findings, we would have expected a robust CD9 expression profile in the F98 cell line. This result further underscores some of the molecular discrepancies between rat glioma models and human gliomas.
Glioma Neovascularization
During cancer progression (invasiveness or metastasis), angiogenesis or neovascularization is essential. Key players in the formation of new blood vessels include growth factor molecules such as VEGF and its receptor, and adhesion molecules and matrix proteins including members of the integrin family as well as the MMPs. Expression of VEGF is increased in gliomas and appears to correlate with tumor grade. 33 When we examined the expression of several of these key molecules we found that in all four cell lines there was a consistent increase in expression relative to rat astrocytes for VEGF and integrin-␣ as well as the integrin-␤4 gene. Nevertheless, there was a deviation in the C6 line in the expression of MMPs, specifically MMP-7. That is, in the C6 cell line there was no change in gene expression of MMP-7, whereas there was a corresponding increase in MMP-7 in all of the other cell lines tested.
Profiling of the tumor cell lines for the expression of another regulator of angiogenesis, the HGF, was also performed. The HGF is overexpressed in gliomas and has been shown to contribute to tumor growth and angiogenesis both in vivo and in vitro. 28, 29, 36 During the evaluation, no significant change in HGF expression in the tumor cell lines relative to rat astrocytes was observed.
Endothelial cells associated with glioma neovascularization play a role in tumor resistance to chemotherapy. A significant obstacle in the treatment of the disease is presented through the concomitant increase in the expression of the MDR2 gene. Expression of MDR2 by tumor cells clearly has implications for chemotherapy resistance; an increase in MDR gene expression results in the inability to provide chemotherapy systemically in nontoxic concentrations. In our analyses, an increase in the expression of the MDR2 genes was noted in all of the cell lines, indicating that none of these lines are good candidates for experiments designed to explore new chemotherapy regimens.
Glioma Infiltration
The refractoriness of human malignant gliomas to surgical therapy is partly related to the highly infiltrative nature of these tumors. The process of infiltration requires the breakdown of cellular adhesions and the extracellular matrix, and the upregulation of proteins associated with cytoskeletal motility. Downstream targets of the Ras pathway, including members of the MMP family, were examined (see following discussion). We noted a significant increase in MMP-7 in three of the four cell lines relative to rat astrocytes. This proteolytic protein plays a key role in digestion of the extracellular matrix, allowing tumor invasion.
The activity of the metalloproteinase enzymes is inhibited by TIMPs. Of the members of the TIMP family that have been characterized, the role of TIMP-1 in cancer remains unresolved, but it has been reported that TIMP-1 mRNA is upregulated in many human cancers. The TIMP-1 gene product induces proliferation in many cell types, regulates apoptosis and the activation of angiogenesis, as well as metastasis and cellular infiltration. 19, 35 In a recent study conducted in transgenic mice, investigators examined both the temporal and spatial expression of TIMP-1 and demonstrated that the mRNA expression increased during neoplastic progression. 35 Contrary to what has been reported in human cancers and in mouse studies, however, we observed a decrease in TIMP-1 expression in all the cell lines we tested. This observation is consistent with earlier reports which suggested that a decrease in expression or the loss of functional TIMP-1 due to mutation was associated with increased tumor invasiveness. 2, 24 The expression of FAK was of interest because this protein mediates the integrin signal transduction pathways. Activation of FAK by integrin promotes cell spreading, migration, and proliferation while inhibiting apoptosis. 7 Integrin-␣ expression was increased in all of the glioma cell lines relative to rat astrocytes; however, increased FAK expression was only evident in the F98 cell lines. Elevated FAK levels have been associated with anaplastic astrocytomas, and it has been suggested that this could be responsible for increased Ras activation in these tumors. 16, 17 The increase in integrin and FAK expressions could imply increased activation of genes that are critical to glioma migration in the rat glioma cell lines.
Expression of the FGF in conjunction with its receptors is very important for cell growth and angiogenesis. Although this finding was unexpected, alternative mechanisms for increased FGF-mediated signaling have been described in gliomas. For instance, increased FGFR affinity is one such mechanism. In glial tumors, one of the receptor subtypes known as FGFR-1 has a spliced variant, which has a 10-fold increased affinity for FGF. 48 This splice variant was not included in our array. Nevertheless, there was decreased expression of wild-type FGFR-1 in three of the four tumor cell lines compared with rat astrocytes. It has been suggested that the FGFR-1 spliced variant plays a crucial role in FGFR signaling in human gliomas. 21 The VEGF gene product is an important mediator of angiogenesis. In this analysis we probed its expression level as well as those of the HGF in each of the rat tumor cell lines. The observation was made that VEGF demonstrated a significant increase in expression in the tumor lines, whereas no significant change was observed in HGF expression. It might therefore appear that VEGF is a more prominent regulator of angiogenesis than is HGF in the rat glioma cell lines.
CONCLUSIONS
Glioma models in rats have served as excellent models of tumor behavior with respect to therapy, and as vital sources of insight into the molecular biology of gliomas. The four rat glioma cell lines used in our experiments were originally derived from the mutagenicity that developed following treatment with a nitrosourea derivative. It is important to realize that cells in culture undergo multiple passages, that these cells may have undergone genetic and epigenetic changes that were selected for during their passage, and that furthermore, this may have affected the gene expression results. In addition, not much is known about the extent to which these rat cell lines are molecularly analogous to human gliomas. We have presented for the first time a comparative microarray analysis of differential gene expression in four commonly used rat tumor cell lines (C6, 9L, F98, and RG2).
In cancer, the mechanisms for up-or downregulation of genes include amplification or deletion of chromosomal regions, or methylation of the promoter regions of the genes. It is important to realize that cells in culture undergo many passages and may have acquired genetic and epigenetic changes; however, microarray technology provides a unique means of comparing gene expression between glioma cell lines and rat astrocytes. Clearly, because the arrays only encompassed 1176 rat cDNAs, our examination of rat glioma genetic expressions is not comprehensive. Nevertheless, we were able to obtain expression profiles for many genes that have been associated with and deemed critical to glioma biology. Based on histological and morphological features, the cell lines thought to resemble GBMs most closely are F98 and RG2. Nonetheless, our data demonstrate that the closest similarity is observed in the C6 cell line.
With respect to glioma proliferation, the overall profiles for all of the rat glioma cell lines were somewhat similar to those found in human gliomas, but again the C6 cell line was the closest match based on the limited number of genes that were available on our microarray platforms. Microarrays that encompass the entire genome of the model system will provide the best representation of how closely these systems imitate human brain tumors. Hence, whenever an animal model is used, careful experimental design along with a gene expression profile should be mandated as a prerequisite to elucidate which animal model or cell line will be experimentally optimal for future investigations.
